We're off to the races!

Octapharma Receives Orphan Drug Exclusivity Approval for wilate(R …

Octapharma Receives Orphan Drug Exclusivity Approval for wilate(R
FOXBusiness
“Orphan drug exclusivity confirms Octapharma’s decision to focus exclusively on the treatment of von Willebrand patients. Wilate has a combination of two
Octapharma Receives Orphan Drug Exclusivity Approval for wilate(R

 

 

 

Read more news.

en_USEnglish